Clinical complications of heterologous antisera administration

von Behring, 1890, Uber das zustandekommen der diphtherie-immunitat und der tetanus-immunitat, Deutsch Med Wochenschr, 16, 1113, 10.1055/s-0029-1207589 Beclere, 1896, Experimental studies of post-therapeutic lesions, Annales de l’lnstitut Pasteur, 10, 567 Daut, 1897, Zur Statistike der serumexanthene, Jahrb fuer Kinderhailk, 289 Richet, C. Anaphylaxis. Translated by J. M Bligh, Liverpool: The University Press. 1913. Von Pirquet, C.R. and Schick, B. Serum sickness. Translated by B. Schick. Baltimore: Williams and Wilkins, 1951. Starzl, 1967, The clinical use of antilymphocyte globulin in renal hemotransplantation, Transplant, 5, 1100, 10.1097/00007890-196707001-00045 Bielory, 1986, Bone marrow failure: Immunological implications and treatment modalities, Ann. Allergy, 56, 114 Ritz, 1981, Serotherapy of acute lymphoblastic leukemia with monoclonal antibody, Blood, 58, 141, 10.1182/blood.V58.1.141.141 Brendel, 1972, The treatment of autoimmune diseases with ALG, Behring Inst. Mitt, 51, 176 Russell, 1980, Snake venom poisoning in the United States, Ann Rev Med, 31, 247, 10.1146/annurev.me.31.020180.001335 Russell, 1982, Treatment of snake bites in the U.S.A, Med Lett Drugs Ther, 24, 87 Lamson, 1924, Fatal anaphylaxis and sudden death associated with the injection of foreign substances, JAMA, 82, 1091, 10.1001/jama.1924.02650400001001 James, 1964, Fatal systemic anaphylaxis in man, NEJM, 270, 597, 10.1056/NEJM196403192701202 Sheffer, 1980, Exercise induced anaphylaxis, JACI, 66, 106 Wasserman, 1983, Mediators of immediate hypersensitivity, JACI, 72, 101 Benveniste, 1914, Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils, Nature, 249, 581, 10.1038/249581a0 Waldbott, 1949, Anaphylactic death from penicillin, JAMA, 139, 526, 10.1001/jama.1949.72900250002008 Umetsu, 1985, Serum sickness triggered by anaphylaxis: A complication of immunotherapy, JACI, 76, 713 Fellner, 1967, Double reaction to penicillin: Anaphylactic and serumsickness like reactions due to a single dose, Arch Derm, 96, 687, 10.1001/archderm.1967.01610060081013 O’Connor, 1964, Death from a ‘wasp’ sting, Ann Allergy, 22, 385 Burman, 1973, Acute anaphylaxis, pulmonary edema, and intravascular hemolysis due to cryoprecipitate, Arch Dis Child, 48, 483, 10.1136/adc.48.6.483 Vyas, 1975, Health blood donors with selective absence of immunoglobulin A: Prevention of anaphylactic transfusion reactions caused by antibodies to IgA, J Lab Clin Med, 85, 838 Idsoe, 1968, Nature and extent of penicillin sidereactions with particular reference to fatalities from anaphylactic shock, Bull W.H.O, 38, 159 Stark, 1986, Biphasic and protracted anaphylaxis, J. Allergy Clin Immunol, 78, 76, 10.1016/0091-6749(86)90117-X Siegel, 1962, Anaphylaxis, Ped Clin North Am, 9, 29, 10.1016/S0031-3955(16)31227-5 Delange, 1972, Anaphylactic deaths, A clinicolpathologic study of 43 cases, J Forensic Sci, 17, 525 Hunt, 1943, Death from allergic shock, NEJM, 228, 502, 10.1056/NEJM194304222281602 Squire, 1950, The relationship between horse dandruff and horse serum antigens in asthma, Clin Sci, 9, 127 Park, 1924, Human hypersensitiveness to whole horse serum or serum globulins following diphtheria toxin antitoxin injections, J Immunol, 9, 17, 10.4049/jimmunol.9.1.17 Davis, 1938, Horse serum skin tests, J Hygiene, 38, 325, 10.1017/S0022172400011190 Belin, 1977, Diagnostic tests in skin and serum of workers sensitized to Bacillus subtilis enzymes, Clin Allergy, 7, 55, 10.1111/j.1365-2222.1977.tb01425.x Dolovich, 1972, Correlates of skin test reactions to Bacillus subtilis enzyme preparations, JACI, 49, 43 Loprinzi, 1983, Snake antivenin administration in a patient allergic to horse serum, South Med J, 76, 501, 10.1097/00007611-198304000-00024 Reisman, 1962, Penicillin allergy and desensitization, J. Allergy, 33, 178, 10.1016/0021-8707(62)90007-2 Falleroni, 1968, Treatment of allergic emergencies, Mod Treatment, 5, 782 Casterline, 1977, Further studies on the mechanism of human histamine-induced asthma, J. Allergy Clin Immunol, 59, 420, 10.1016/0091-6749(77)90004-5 Drazen, 1978, H2 receptor mediated inhibition of immediate type hypersensitivity reaction in vivo, Amer Rev Respir Dis, 117, 479 Kaliner, 1981, Effects of infused histamine: Analysis of H1 and H2 histamine receptor antagonists on cardiovascular and pulmonary response, J. Allergy Clin Immunol, 68, 365, 10.1016/0091-6749(81)90134-2 Kaliner, 1982, Effects of infused histamine: Correlation of plasma histamine levels and symptoms, J. Allergy Clin Immunol, 69, 283, 10.1016/S0091-6749(82)80005-5 Myers, 1981, Cimetidine combined with steroids and H1 antihistamines for the prevention of serious radiographic contrast media reactions, Cathet Cardiovasc Diag, 7, 65, 10.1002/ccd.1810070109 Bielory, 1985, Anaphylactoid reactions to radiocontrast materials, Intern Anesth Clin, 23, 97, 10.1097/00004311-198511000-00007 Axeinow, 1913, 683 Falle von Serumkrankheit, Jahrbu Kinder, 78, 565 Iga, 1930, Ueber Herdreaktionen an den unberuhretn Augen nach parenteraler Zufuhr von artfremden Serum, Klin Monatsbl Augenheilkd, 84, 449 Kojis, 1942, Serum sickness and anaphylaxis: Analysis of cases of 6,211 patients treated with horse serum for various infections, Am J Dis Child, 64, 313, 10.1001/archpedi.1942.02010080107012 Ratner, 1943 Dixon, 1958, Pathogenesis of serum sickness, Arch Path, 65, 18 Sherman, 1958, Serum sickness – 1957, Int Arch Allergy, 12, 59, 10.1159/000228443 Reynolds, 1966, Serum sickness: An old problem with new implications, Ann Allergy, 24, 337 Serum sickness. JAMA 1973; 224, 726. Bielory, 1984, Serum sickness from antithymocyte globulin administration, ii Lawley, 1989, A prospective clinical and immunologic analysis of patients with serum sickness, N. Engl J Med, 311, 1407, 10.1056/NEJM198411293112204 Bielory, 1988, Human serum sickness: A prospective clinical, immunological and immunopathological analysis of 35 patients treated with antithymocyte globulin, Medicine, 67, 40, 10.1097/00005792-198801000-00003 Longcope, 1943, Serum sickness and analogous reactions from certain drugs, particularly the sulphonamides, Medicine, 22, 521, 10.1097/00005792-194309000-00003 Deswarte, 1980, Drug allergy, 452 Corrigan, 1978, Clinical reactions to antivenin, 457 Gewurz, 1970, Reactivities to horse anti-lymphocyte globulin, Int Arch Allergy, 39, 210, 10.1159/000230349 Lance, 1973, Antilymphocyte serum, Adv Immunol., 17, 1, 10.1016/S0065-2776(08)60731-2 Hosty, 1953, Incidence of reactions to antirabies horse serum, Public Health Rep, 68, 789, 10.2307/4588549 Toogood, 1960, Allergic reactions to antitetanus serum, Can Med J, 82, 907 Karliner, 1965, Incidence of reactions following administration of antirabies serum: Study of 526 cases, JAMA, 193, 350, 10.1001/jama.1965.03090050035009 MacKenzie, 1930, Serum disease and serum accidents, JAMA, 94, 260, 10.1001/jama.1930.27120300002010 Hartung, 1896, Die Serumexantheme bei Diphtheric, Jahrb Kinderh, 42, 72 Moynihan, 1955, Serum sickness and local reactions in tetanus prophylaxis: A study of 400 cases, Lancet, 2, 264, 10.1016/S0140-6736(55)92690-8 Sullivan, 1987, Past, present and future immunotherapy in snake venom poisoning, Ann Emerg Med, 16, 938, 10.1016/S0196-0644(87)80737-0 Bielory, 1985, Cutaneous manifestations of serum sickness in patients antithymocyte globulin, J. Amer Acad Dermatol, 85, 411, 10.1016/S0190-9622(85)70182-X Lawley, 1985, A study of human serum sickness, J. Invest Dermatol, 85, 1295, 10.1111/1523-1747.ep12275641 Gower, 1978, Small vessel vasculitis and HBsAG, J. Allergy Clin Immunol, 62, 222, 10.1016/0091-6749(78)90211-7 Andrews, 1979, Circulating and tissue immune complexes in cutaneous vasculitis, J Clin Lab Immunol, 1, 311 Braverman, 1975, Demonstration of immune complexes in spontaneous and histamine-induced lesions and in normal skin of patients with leukocytoclastic angiitis, J Invest Derm, 64, 105, 10.1111/1523-1747.ep12510321 Boots, 1923, The arthritis of serum sickness, JAMA, 80, 12, 10.1001/jama.1923.02640280014005 Weaver, 1909, Serum disease, Arch Int Med, 3, 485, 10.1001/archinte.1909.00050160118010 Clarkson, 1986, Blockade of clearance of immune complexes by anti-Fe gamma receptor monoclonal antibody, J Exp Med, 164, 474, 10.1084/jem.164.2.474 Atkinson, 1914, Studies on the in vivo antibody and complement in the immune clearance of and destruction of erythrocytes in man, J Clin Inv, 54, 339, 10.1172/JCI107769 Frank, 1979, Defective reticuloendothelial system Fc-Receptor function in systemic lupus erythematosus, N Engl J Med, 300, 518, 10.1056/NEJM197903083001002 Clark, 1937, Endocardial, arterial and other parenchymal alterations associated with serum disease in man, Arch Path, 24, 548 Van Zandt Hawn, 1947, Histological and serological sequences in experimental hypersensitivity, J Exp Med, 85, 571, 10.1084/jem.85.6.571 Hermitte, 1931, Paralysies postserotherapiques et maladie du serum, Rev Neurol, 38, 347 Cutter, 1936, Auditory nerve involvement after tetanus antitoxin: First reported case, JAMA, 106, 1006, 10.1001/jama.1936.92770120004011c Bennett, 1939, Horse serum neuritis, JAMA, 112, 590, 10.1001/jama.1939.02800070006002 Bardenwerper, 1962, Serum neuritis from tetanus antitoxin, JAMA, 179, 763, 10.1001/jama.1962.03050100017004 Brown, 1915, Ocular manifestations of serum sickness, Amer J Ophthalmol, 8, 614, 10.1016/S0002-9394(25)90848-3 Mason, 1992, Optic neuritis in serum sickness, JAMA, 78, 88, 10.1001/jama.1922.02640550010004 Bedell, 1935, Stereoscopic fundus photography, JAMA, 105, 1502, 10.1001/jama.1935.02760450022005 Wong, 1971, Endogenous immune uveitis: The role of serum sickness, Arch Ophth, 85, 93, 10.1001/archopht.1971.00990050095015 Dixon, 1961, Experimental glomerulonephritis. The pathogenesis of a lab model resembling the spectrum of human glomerulonephritis, J Exp Med, 113, 899, 10.1084/jem.113.5.899 Unanue, 1967, Experimental glomerulonephritis: Immunological events and pathogenetic mechanisms, Adv Immunol, 6, 1, 10.1016/S0065-2776(08)60521-0 Bartolotti, 1978, Delayed removal of renal-bound antigen in decomplemented rabbits with acute serum sickness, Clin Exp Immunol, 32, 199 Kashiwagi, 1968, Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts, Ann Int Med, 68, 275, 10.7326/0003-4819-68-2-275 Pincus, 1968, Experimental chronic glomerulitis, J Exp Med, 127, 819, 10.1084/jem.127.4.819 Guinon, 1895, Un Cas d’anguine membraneuse par le serum de roux; mort avec anurie et convulsions uremiques, Semaine Medicate, 300 De La Pava, 1962, Fatal glomerulonephritis after receiving horse anti-human-cancer serum: Report of 3 cases, Arch Int Med, 109, 391, 10.1001/archinte.1962.03620160017003 Ley, 1957, Changes in white blood cell and bone marrow morphology and serum protein fractions in induced and spontaneous hypersensitivity states, J. Allergy, 28, 220, 10.1016/0021-8707(57)90126-0 Schmidt, 1963, Peripheral plasmacytosis in serum sickness, Ann Intern Med, 59, 542, 10.7326/0003-4819-59-4-542 Barnett, 1963, Serum sickness and plasmacytosis: clinical, immunology and hematologic analysis, Amer J Med, 35, 113, 10.1016/0002-9343(63)90168-2 Bryant, 1979, Laboratory immunology and serology Davidson, 1929, Heterophile antibodies in serum sickness, J Immunol, 16, 259, 10.4049/jimmunol.16.3.259 Gormsen, 1941, Behavior of sedimentation reaction serum proteins in serum sickness, Nord Med, 11, 2125 Longcope, 1918, Relation of circulating antibodies to serum disease, J Exp Med, 27, 341, 10.1084/jem.27.3.341 Longcope, 1920, The relation between the disappearance of foreign proteins from circulation and the formation of antibodies, Proc Soc Exp Bio Med, 17, 133, 10.3181/00379727-17-73 Reisman, 1961, Serum sickness: II. Demonstration and characteristics of antibodies, J Allergy, 32, 531, 10.1016/0021-8707(61)90008-9 Bielory, 1984, Immunoglobulin levels during serum sickness from antithymocyte globulin, J Allergy Clin Immunol, 73, 154a Bielory, 1985, Human serum sickness: Serological changes, Ann Allergy, 54, 344a Bielory, 1990, IgG subclass antibody production in human serum sickness, JACI, 85, 573 Bielory, 1986, Serum Sickness, 638 Kniker, 1971, Prevention of immune complex disease (serum sickness) by antagonists of vasoactive amines, Pediatr Res, 5, 381, 10.1203/00006450-197108000-00045